Imunon, Inc. (IMNN)
NASDAQ·Healthcare·Biotechnology
$2.73
-2.50%
Mkt Cap $8.06M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$1.43 | -$1.29 | +9.79% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$1.73 | -$1.16 | +32.95% | — | — |
| Q3 2025 Aug 5, 2025 | — | — | — | -$3.09 | -$1.87 | +39.48% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$4.56 | -$3.65 | +19.96% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.36 | -$0.23 | +36.11% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.37 | -$0.34 | +8.11% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.55 | -$0.51 | +7.27% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.57 | -$0.52 | +8.77% | — | — |
| Q1 2024 Mar 28, 2024 | — | $7.05M | — | -$0.59 | -$0.52 | +11.86% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.66 | -$0.37 | +43.94% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.71 | -$0.61 | +14.08% | — | — |
| Q2 2023 May 11, 2023 | $62.50K | — | — | -$0.69 | -$0.68 | +1.45% | — | — |
| Q1 2023 Mar 30, 2023 | $120.00K | $125.00K | +4.17% | -$0.80 | -$0.64 | +20.00% | — | — |
| Q4 2022 Nov 14, 2022 | $108.33K | $125.00K | +15.38% | -$0.81 | -$0.87 | -7.41% | — | — |
| Q3 2022 Aug 15, 2022 | $108.33K | $125.00K | +15.38% | -$1.12 | -$0.87 | +22.32% | — | — |
| Q2 2022 May 16, 2022 | $108.33K | $125.00K | +15.38% | -$0.99 | -$1.82 | -83.84% | — | — |
| Q1 2022 Mar 31, 2022 | $112.50K | $125.00K | +11.11% | -$0.90 | -$3.62 | -302.22% | — | — |
| Q4 2021 Nov 15, 2021 | $120.00K | $125.00K | +4.17% | -$1.20 | -$0.90 | +25.00% | — | — |
| Q3 2021 Aug 12, 2021 | $156.25K | $125.00K | -20.00% | -$1.20 | -$0.90 | +25.00% | — | — |
| Q2 2021 May 14, 2021 | — | $125.00K | — | — | -$1.35 | — | — | — |